Understanding Interactions of Smoking on Prognosis of HPV-Associated Oropharyngeal Cancers.
Missak HaigentzCarlos SuarezPrimoz StrojanJuan P RodrigoAlessandra RinaldoCarol R BradfordJune CorryRobert P TakesAlfio FerlitoPublished in: Advances in therapy (2018)
The new 8th edition AJCC/UICC staging system for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC), developed to account for improved survival outcomes over HPV-negative cancers, includes anatomic features strictly associated with tumor-node-metastasis (TNM) and does not account for patient-specific characteristics that may impact prognosis. This commentary evaluates the evidence of smoking as an adverse prognostic factor in HPV-associated OPSCC. We review the multifactorial biological, clinical, and social/behavioral characteristics of smokers with OPSCC that impact outcomes, discuss current challenges with incorporating smoking history in prognostic classifications, and consider opportunities for future investigation.